(Q52037188)

20 April 2018

title

Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. (English)

1 reference

20 April 2018

0 references

1 reference

2

Lisanby S

1 reference

20 April 2018

author name string

Devanand DP

1

1 reference

20 April 2018

Lo ES

3

1 reference

20 April 2018

Fitzsimons L

4

1 reference

20 April 2018

Cooper TB

5

1 reference

20 April 2018

Halbreich U

6

1 reference

20 April 2018

Sackeim HA

7

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

20 April 2018

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Biological Psychiatry

1 reference

20 April 2018

volume

44

1 reference

20 April 2018

issue

7

1 reference

20 April 2018

page(s)

610-616

1 reference

20 April 2018

Diencephalic stimulation and the effects of ECT in endogenous depression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Hypophyseal response to ECT: a higher and faster vasopressin peak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Influence of oxytocin on human memory processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Prolactin modulates oxytocin mRNA during lactation by its action on the hypothalamo-neurohypophyseal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Cerebrospinal fluid vasopressin--changes in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Vasopressin in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Role of oxytocin in memory and amnesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

A placebo-controlled evaluation of vasopressin for ECT-induced memory impairment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Inhibitory effect of atropine on the isoprenaline-induced increase in vasopressin plasma concentration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

The role of corticotropin-releasing factor in the pathogenesis of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Vasopressin in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Current intensity and oxytocin release after electroconvulsive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Effects of electrode placement on the efficacy of titrated, low-dose ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Oestrogen-stimulated neurophysin and outcome after electroconvulsive therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Treatment outcome, seizure duration, and the neurophysin response to ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Improvement in depressive illness is not associated with altered release of neurophysins over a course of ECT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Antidiuretic hormone concentrations following midazolam premedication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Predictors of retrograde amnesia following ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Vasopressin release during electroconvulsive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Prolactin levels after bilateral and unilateral ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Effects of vasopressin on human memory functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

Effect of Stimulus Intensity on Prolactin and Cortisol Release Induced by Unilateral Electroconvulsive Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900086-9

10.1016/S0006-3223(98)00086-9

7 January 2021

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018